Free Trial

Guardian Pharmacy Services (NYSE:GRDN) Stock Price Up 3.8% - Time to Buy?

Guardian Pharmacy Services logo with Medical background
Remove Ads

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report)'s share price shot up 3.8% on Tuesday . The stock traded as high as $21.46 and last traded at $21.34. 20,571 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 155,852 shares. The stock had previously closed at $20.55.

Guardian Pharmacy Services Stock Down 1.3 %

The business has a 50-day moving average of $20.55.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. R Squared Ltd purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $30,000. Investment Research & Advisory Group Inc. purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $34,000. BNP Paribas Financial Markets purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $37,000. Compass Financial Services Inc purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $58,000. Finally, JPMorgan Chase & Co. purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $77,000.

About Guardian Pharmacy Services

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Featured Articles

Should You Invest $1,000 in Guardian Pharmacy Services Right Now?

Before you consider Guardian Pharmacy Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.

While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads